1887

n Cardiovascular Journal of South Africa - Percutaneous closure of interatrial defects : the Free State experience : cardiovascular topics

Volume 15, Issue 1
  • ISSN : 1680-0745
USD

 

Abstract

<I>Objective</I>: Atrial septal defects and patent foramen ovale can now be closed percutaneously. This report describes our initial and follow-up experience, especially in relation to efficacy and complications. <br><I>Methods</I>: During a 2-year period, seven atrial septal defects and one patent foramen ovale were closed. The Amplatzer&lt;sup&gt;(R)&lt;/sup&gt; atrial septal defect occluder was used in five, the Cardioseal&lt;sup&gt;(R)&lt;/sup&gt; device in two and the Amplatzer<sup>(R)</sup> patent foramen ovale occluder in one. A compliant sizing balloon was used to assess the stretched diameter of the defects. <br><I>Results</I>: Percutaneous closure was successful in all patients. The median age was 5.4 years (range: 3.7-16.6 years) and median weight was 18 kg (range: 14-65 kg). The mean duration of the procedure was 2.3 hours. There were no acute complications. Patients were followed up for a mean of 1.1 years. One child experienced severe headaches and another developed an atrial flutter and a small leak 7 months after implantation, both of which resolved. <br><I>Conclusion</I>: Percutaneous closure of atrial septal defects and patent foramen ovale is effective and safe. In selected children, this may be offered as an alternative to surgery.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/cardio/15/1/EJC23878
2004-01-01
2017-02-25

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error